• 11 - First-line BMT for Severe Aplastic Anemia, Pt. 1: Outcomes and Equity

  • 2024/06/11
  • 再生時間： 26 分
  • ポッドキャスト

11 - First-line BMT for Severe Aplastic Anemia, Pt. 1: Outcomes and Equity

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this two-part episode, Amy DeZern, MD, MHS, with Johns Hopkins and Christin DeStefano, MD, with Uniformed Services University discuss bone marrow transplant as a first-line treatment for severe aplastic anemia, moving beyond the limitations of traditional immunosuppressive therapies for a curative treatment option.

    In Part I: Outcomes and Equity, guests explore the benefits of haploidentical transplant, noting quicker recovery times and reduced complications compared to past methods. These advancements are particularly impactful for diverse populations, including military personnel.

    To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

In this two-part episode, Amy DeZern, MD, MHS, with Johns Hopkins and Christin DeStefano, MD, with Uniformed Services University discuss bone marrow transplant as a first-line treatment for severe aplastic anemia, moving beyond the limitations of traditional immunosuppressive therapies for a curative treatment option.

In Part I: Outcomes and Equity, guests explore the benefits of haploidentical transplant, noting quicker recovery times and reduced complications compared to past methods. These advancements are particularly impactful for diverse populations, including military personnel.

To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

身体的病い・疾患 衛生・健康的な生活
続きを読む 一部表示

11 - First-line BMT for Severe Aplastic Anemia, Pt. 1: Outcomes and Equityに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。